Searchable abstracts of presentations at key conferences in endocrinology

ea0026p306 | Obesity | ECE2011

Development and characterization of high-affinity leptins and leptin antagonists

Shpilman M , Niv-Spector L , Katz M , Varol C , Solomon G , Elinav E , Gertler A

Leptin is a pleiotropic hormone acting both centrally and peripherally. It participates in variety of biological processes including energy metabolism, reproduction and modulation of the immune response. So far structural elements affecting leptin binding to its receptor remain unknown. We employed random mutagenesis of leptin, followed by selection of high-affinity mutants by yeast-surface display and discovered that replacing residue D23 with a non-negatively charged amino a...

ea0005p115 | Endocrine Tumours and Neoplasia | BES2003

Prostate and ovarian cancer cell responses to treatment with 2-substituted oestrogen sulphamates in vitro

Day J , Newman S , Comninos A , Solomon C , Purohit A , Leese M , Potter B , Reed M

2-Methoxyoestradiol (2-MeOE2) is a human endogenous metabolite of oestradiol which is known to inhibit the proliferation of breast cancer cells. Sulphamoylation of 2-MeOE2 greatly enhances its ability to inhibit breast cancer cell proliferation and induce apoptosis. To establish whether 2-MeOE2 and its mono- and bis-sulphamoylated derivatives would also be an effective treatment for other endocrine cancers, we have investigated their effects, and those of 2-ethyloestradiol (2-...